They are just engrossed with Remplir US expansion is all, per...

  1. 10,495 Posts.
    lightbulb Created with Sketch. 8834
    They are just engrossed with Remplir US expansion is all, per this update. The asset is there and the ATI/ACI science is making money, just elsewhere alas. Vericel has for example made (USD) $165 million in 2023, $197 millioin in 2024 and 2025 net revenue expected to be approximately $240 million.

    Still served financial purpose, as without the seed money from ACI, Orthocell and Striate (with its partnership with HenrySchein/BioHorizons) and Remplir, etc, etc, would not be of course....
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.